Sweden rejects prostate cancer screening
This article was originally published in Clinica
Executive Summary
Comprehensive screening for early symptoms of prostate cancer cannot be justified at present, Sweden's government committee on the evaluation of medical methodology (SBU) has decided. In the absence of proven diagnostic techniques able to differentiate between tumours which will develop slowly and more aggressive growths, the committee concluded it could not recommend the introduction of a nationwide screening programme, says Lakartidningen (No 21, 1995).